Results 51 to 60 of about 22,246,700 (213)

Alpha interferon restricts human T-lymphotropic virus type 1 and 2 De Novo infection through PKR activation [PDF]

open access: yes, 2013
International audienceType I interferon (IFN-I) inhibits the replication of different viruses. However, the effect of IFN-I on the human T-lymphotropic virus type 1 (HTLV-1) viral cycle is controversial.
Alais, Sandrine   +7 more
core   +4 more sources

Sexual transmission of human T-cell lymphotropic virus type 1 [PDF]

open access: yes, 2014
Human T-cell lymphotropic virus type 1 (HTLV-1) is endemic in many parts of the world and is primarily transmitted through sexual intercourse or from mother to child.
Casseb, Jorge Simão do Rosário   +1 more
core   +1 more source

Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4

open access: yesRetrovirology, 2009
Background Human T-lymphotropic virus type 4 (HTLV-4) is a new deltaretrovirus recently identified in a primate hunter in Cameroon. Limited sequence analysis previously showed that HTLV-4 may be distinct from HTLV-1, HTLV-2, and HTLV-3, and their simian ...
Wolfe Nathan D   +11 more
doaj   +1 more source

Vírus Linfotrópicos de células T humanas (HTLV-1 e HTLV-2): revisão de literatura / Human T-cell lymphotropic viruses (HTLV-1 and HTLV-2): literature review

open access: yesBrazilian Journal of Health Review, 2021
Os vírus linfotrópicos de células T humanas (HTLV) foram os primeiros retrovírus potencialmente oncogênicos a serem descobertos e isolados no mundo. Estima-se que 15 a 20 milhões de pessoas estejam infectadas pelo vírus. Até a atualidade, quatro variantes foram descobertas e descritas: HTLV-1, 2, 3 e 4.
Lima, Victor Fernando da Silva   +4 more
openaire   +2 more sources

Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2014
Introduction The prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection is heterogeneous across different populations. We tested the hypothesis that HTLV-1/2 infection occurs more often in dermatological patients.
Leny Nascimento da Motta Passos   +6 more
doaj   +1 more source

Prevalence and risk factor analysis for HIV/HTLV 1/2 coinfection in Paraíba state, Brazil

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: Human T-lymphotropic virus (HTLV) 1 and 2 infections can lead to neurological diseases, mainly in HIV/HTLV 1 coinfected. Furthermore, HTLV 1 infection in HIV/AIDS patients has also been associated with AIDS progression.
Marcela Santos de Souza   +6 more
doaj   +1 more source

Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada [PDF]

open access: yes, 2014
The 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses was held in Montreal, Québec from June 26 to June 30, 2013 and was therefore hosted by a Canadian city for the first time.
Barbeau, Benoit   +10 more
core   +4 more sources

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis

open access: yesViruses, 2010
Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo.
Patrick L. Green, Priya Kannian
doaj   +1 more source

Prevalence of human T-lymphotropic virus type 1 and 2 (HTLV-1/-2) infection in pregnant women in Brazil: a systematic review and meta-analysis

open access: yesScientific Reports, 2021
Human T-lymphotropic virus type 1 (HTLV-1) infection may cause serious disease, while pathogenicity of HTLV-2 is less certain. There are no screening or surveillance programs for HTLV-1/-2 infection in Brazil.
Bruna Angelo Vieira   +5 more
doaj   +1 more source

A New Flow Cytometry-Based Single Platform for Universal and Differential Serodiagnosis of HTLV-1/2 Infection

open access: yesFrontiers in Immunology, 2022
In the present work, we developed and evaluated the performance of a new flow cytometry-based single platform, referred to as “FC-Duplex IgG1 (HTLV-1/2)”, for universal and differential serodiagnosis of HTLV-1/2 infection. The proposed technology employs
Luciene Pimenta de Paiva   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy